207 related articles for article (PubMed ID: 30401353)
1. Medication-Assisted Treatment Considerations for Women with Opiate Addiction Disorders.
Jacobs AA; Cangiano M
Prim Care; 2018 Dec; 45(4):731-742. PubMed ID: 30401353
[TBL] [Abstract][Full Text] [Related]
2. The Washington State Hub and Spoke Model to increase access to medication treatment for opioid use disorders.
Reif S; Brolin MF; Stewart MT; Fuchs TJ; Speaker E; Mazel SB
J Subst Abuse Treat; 2020 Jan; 108():33-39. PubMed ID: 31358328
[TBL] [Abstract][Full Text] [Related]
3. Sex differences in opioid use and medical issues during buprenorphine/naloxone treatment.
Barbosa-Leiker C; McPherson S; Layton ME; Burduli E; Roll JM; Ling W
Am J Drug Alcohol Abuse; 2018; 44(4):488-496. PubMed ID: 29672167
[TBL] [Abstract][Full Text] [Related]
4. Patient perceptions of treatment with medication treatment for opioid use disorder (MOUD) in the Vermont hub-and-spoke system.
Rawson RA; Rieckmann T; Cousins S; McCann M; Pearce R
Prev Med; 2019 Nov; 128():105785. PubMed ID: 31362002
[TBL] [Abstract][Full Text] [Related]
5. Primary Care-Based Models for the Treatment of Opioid Use Disorder: A Scoping Review.
Korthuis PT; McCarty D; Weimer M; Bougatsos C; Blazina I; Zakher B; Grusing S; Devine B; Chou R
Ann Intern Med; 2017 Feb; 166(4):268-278. PubMed ID: 27919103
[TBL] [Abstract][Full Text] [Related]
6. Geographic and specialty distribution of US physicians trained to treat opioid use disorder.
Rosenblatt RA; Andrilla CH; Catlin M; Larson EH
Ann Fam Med; 2015; 13(1):23-6. PubMed ID: 25583888
[TBL] [Abstract][Full Text] [Related]
7. Medication-Assisted Treatment of Opioid Use Disorder in Adolescents and Young Adults.
Cottrill CB; Matson SC
Adolesc Med State Art Rev; 2014 Aug; 25(2):251-65. PubMed ID: 27132312
[No Abstract] [Full Text] [Related]
8. Diagnosis and Management of Opioid Use Disorder in Hospitalized Patients.
Herscher M; Fine M; Navalurkar R; Hirt L; Wang L
Med Clin North Am; 2020 Jul; 104(4):695-708. PubMed ID: 32505261
[TBL] [Abstract][Full Text] [Related]
9. Use and misuse of opioid replacement therapies: a Queensland study.
Smirnov A; Kemp R
Subst Use Misuse; 2012 Jan; 47(1):78-85. PubMed ID: 22216993
[TBL] [Abstract][Full Text] [Related]
10. Test of a workforce development intervention to expand opioid use disorder treatment pharmacotherapy prescribers: protocol for a cluster randomized trial.
Molfenter T; Knudsen HK; Brown R; Jacobson N; Horst J; Van Etten M; Kim JS; Haram E; Collier E; Starr S; Toy A; Madden L
Implement Sci; 2017 Nov; 12(1):135. PubMed ID: 29141653
[TBL] [Abstract][Full Text] [Related]
11. Multi-model implementation of evidence-based care in the treatment of opioid use disorder in Pennsylvania.
Kawasaki S; Francis E; Mills S; Buchberger G; Hogentogler R; Kraschnewski J
J Subst Abuse Treat; 2019 Nov; 106():58-64. PubMed ID: 31540612
[TBL] [Abstract][Full Text] [Related]
12. The Shelby Clinic Medication-Assisted Treatment for Opioid Addiction.
Penn CL
J Ark Med Soc; 2016 Aug; 113(2):30-32. PubMed ID: 30047628
[No Abstract] [Full Text] [Related]
13. Re-purposing anticoagulation clinics: expanding access to opioid agonist therapy in primary care settings.
Lagisetty P; Heisler M; Bohnert A
Addiction; 2017 Mar; 112(3):384-385. PubMed ID: 27550143
[No Abstract] [Full Text] [Related]
14. Efficacy and safety of a sublingual buprenorphine/naloxone rapidly dissolving tablet for the treatment of adults with opioid dependence: A randomized trial.
Webster L; Hjelmström P; Sumner M; Gunderson EW
J Addict Dis; 2016; 35(4):325-338. PubMed ID: 27267785
[TBL] [Abstract][Full Text] [Related]
15. Group medication management for buprenorphine/naloxone in opioid-dependent veterans.
Berger R; Pulido C; Lacro J; Groban S; Robinson S
J Addict Med; 2014; 8(6):415-20. PubMed ID: 25275875
[TBL] [Abstract][Full Text] [Related]
16. Analysis of barriers to adoption of buprenorphine maintenance therapy by family physicians.
DeFlavio JR; Rolin SA; Nordstrom BR; Kazal LA
Rural Remote Health; 2015; 15():3019. PubMed ID: 25651434
[TBL] [Abstract][Full Text] [Related]
17. Buprenorphine Supply, Access, and Quality: Where We Have Come and the Path Forward.
Breen CT; Fiellin DA
J Law Med Ethics; 2018 Jun; 46(2):272-278. PubMed ID: 30147002
[TBL] [Abstract][Full Text] [Related]
18. Initial strategies for integrating buprenorphine into HIV care settings in the United States.
Sullivan LE; Bruce RD; Haltiwanger D; Lucas GM; Eldred L; Finkelstein R; Fiellin DA
Clin Infect Dis; 2006 Dec; 43 Suppl 4():S191-6. PubMed ID: 17109306
[TBL] [Abstract][Full Text] [Related]
19. A Primary Care Response to COVID-19 for Patients with an Opioid Use Disorder.
Wilson CG; Ramage M; Fagan EB
J Rural Health; 2021 Jan; 37(1):169-171. PubMed ID: 32277732
[No Abstract] [Full Text] [Related]
20. Medication-Assisted Treatment of Adolescents With Opioid Use Disorders.
COMMITTEE ON SUBSTANCE USE AND PREVENTION
Pediatrics; 2016 Sep; 138(3):. PubMed ID: 27550978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]